PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Sarcoidosis D012507 13 associated lipids
Pleurisy D010998 20 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cataract D002386 34 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Sarcoma 180 D012510 21 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Hyperemia D006940 25 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Thrombosis D013927 49 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Peritonitis D010538 38 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Ascariasis D001196 3 associated lipids
Thyroid Diseases D013959 8 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Astrocytoma D001254 15 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Erythema D004890 22 associated lipids
Hyperalgesia D006930 42 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Hyperlipidemias D006949 73 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Cough D003371 19 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Sanchez Mejia RO et al. Matrix-associated transforming growth factor-beta1 primes mouse bone marrow-derived mast cells for increased high-affinity Fc receptor for immunoglobulin E-dependent eicosanoid biosynthesis. 2000 Am. J. Respir. Cell Mol. Biol. pmid:10783127
Feng J et al. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. 2000 J. Lipid Res. pmid:10787429
Macfarlane AJ et al. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. 2000 Am. J. Respir. Crit. Care Med. pmid:10806153
Taba Y et al. Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells. 2000 Circ. Res. pmid:10807869
Sharif NA et al. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids. 2000 J. Pharmacol. Exp. Ther. pmid:10772998
Marvin KW et al. The 15-deoxy-delta(12,14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPARgamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. 2000 Placenta pmid:10833383
Shirahase H et al. Inhibitory effects of PGD2, PGJ2 and 15-deoxy-delta12,14-PGJ2 on iNOS induction in rat mesenteric artery. 2000 Life Sci. pmid:10834301
Bernardo A et al. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. 2000 Eur. J. Neurosci. pmid:10947800
Kozak KR et al. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. 2000 J. Biol. Chem. pmid:10931854
Hartert TV et al. Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma. 2000 Am. J. Respir. Crit. Care Med. pmid:10934099
Maxey KM et al. The nature and composition of 15-deoxy-Delta(12,14)PGJ(2). 2000 Prostaglandins Other Lipid Mediat. pmid:10936412
Clay CE et al. 15-deoxy-Delta(12,14)PGJ(2) induces diverse biological responses via PPARgamma activation in cancer cells. 2000 Prostaglandins Other Lipid Mediat. pmid:10936413
Mc Clay EF The effects of Delta(12)-PGJ(2) on malignant cells. 2000 Prostaglandins Other Lipid Mediat. pmid:10936416
Yokoyama Y et al. Synergistic antiproliferative effect of delta 12-prostaglandin J2 (delta 12-PGJ2) and hyperthermia on human esophageal cancer cell lines. 2000 Hum. Cell pmid:10937344
Davis TL and Sharif NA Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor. 2000 Br. J. Pharmacol. pmid:10952683
Tanaka K et al. Cutting edge: differential production of prostaglandin D2 by human helper T cell subsets. 2000 J. Immunol. pmid:10679060
Chan CL et al. Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells. 2000 Br. J. Pharmacol. pmid:10711359
Urade Y and Hayaishi O Prostaglandin D synthase: structure and function. 2000 Vitam. Horm. pmid:10668396
Li L et al. 15-deoxy-Delta 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. 2001 J. Biol. Chem. pmid:11477100
Ahluwalia P et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. 2001 J. Allergy Clin. Immunol. pmid:11544467
Nicolaidis S et al. [Variations of hypothalamic and cortical prostaglandins and monoamines reveal transitions in arousal states: microdialysis study in the rat]. 2001 Rev. Neurol. (Paris) pmid:11924034
Keelan J et al. 15-deoxy-delta12,14-prostaglandin J2-induced apoptosis in amnion-like WISH cells. 2001 Prostaglandins Other Lipid Mediat. pmid:11785780
Pignatelli M et al. The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. 2001 J. Cell. Sci. pmid:11739643
Gervais FG et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. 2001 J. Allergy Clin. Immunol. pmid:11742277
Reilly TP et al. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. 2001 Chem. Res. Toxicol. pmid:11743745
Takeda K et al. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. 2001 J. Biol. Chem. pmid:11687581
Tanaka T et al. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet. 2001 Life Sci. pmid:11693274
Niyonsaba F et al. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. 2001 Eur. J. Immunol. pmid:11298331
Harris SG and Phipps RP The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. 2001 Eur. J. Immunol. pmid:11298334
Tanaka H and Nagai H [Inflammation-allergy and prostanoids. (2). The role of prostanoids in allergic inflammation]. 2001 Nippon Yakurigaku Zasshi pmid:11338375
Tomlinson JW et al. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. 2001 Endocrinology pmid:11316764
Thévenon C et al. Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. 2001 Clin. Chem. pmid:11274037
Rohn TT et al. 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. 2001 Neuroreport pmid:11277593
Satoh T et al. Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins. 2001 J. Neurochem. pmid:11279261
Drew PD and Chavis JA The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. 2001 J. Neuroimmunol. pmid:11282151
Guyton K et al. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. 2001 J. Leukoc. Biol. pmid:11310850
Govoni S et al. The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. 2001 Neurosci. Lett. pmid:11311500
Tsubouchi Y et al. Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2. 2001 Biochem. Biophys. Res. Commun. pmid:11350047
Wang C et al. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. 2001 Mol. Cell. Biol. pmid:11287611
Jiang JG et al. Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element. 2001 J. Biol. Chem. pmid:11292834
Serghides L and Kain KC Peroxisome proliferator-activated receptor gamma-retinoid X receptor agonists increase CD36-dependent phagocytosis of Plasmodium falciparum-parasitized erythrocytes and decrease malaria-induced TNF-alpha secretion by monocytes/macrophages. 2001 J. Immunol. pmid:11359831
Urquhart P et al. Profile of eicosanoids produced by human saphenous vein endothelial cells and the effect of dietary fatty acids. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11487303
Angeli V et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. 2001 J. Exp. Med. pmid:11369785
Krawiec ME et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. 2001 Am. J. Respir. Crit. Care Med. pmid:11371398
Saarinen JV et al. Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects of leukotriene C4 and prostaglandin D2. 2001 Eur. J. Clin. Pharmacol. pmid:11372583
Buechler C et al. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. 2001 Biochim. Biophys. Acta pmid:11420178
VanderEnde DS and Morrow JD Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after the application of cinnamic aldehyde. 2001 J. Am. Acad. Dermatol. pmid:11423836
Park JM Role of prostaglandins in bladder smooth muscle cell gene expression. 2001 Urology pmid:11378068
Chang TS et al. NQ-Y15 inhibits the calcium mobilization by elevation of cyclic AMP in rat platelets. 2001 Biol. Pharm. Bull. pmid:11379764
Fajas L et al. PPAR gamma: an essential role in metabolic control. 2001 Nutr Metab Cardiovasc Dis pmid:11383325
Boutaud O et al. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid. 2001 Biochemistry pmid:11389610
Chen NG and Han X Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium. 2001 Biochem. Biophys. Res. Commun. pmid:11401521
Lau HY and Chan CL Modulation of intracellular cyclic AMP in immunologically activated rat peritoneal mast cells by prostaglandin D2. 2001 Inflamm. Res. pmid:11411605
Serhan CN and Devchand PR Novel antiinflammatory targets for asthma. A role for PPARgamma? 2001 Am. J. Respir. Cell Mol. Biol. pmid:11415929
Wang AC et al. Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation. 2001 Am. J. Respir. Cell Mol. Biol. pmid:11415933
Eto K et al. Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. 2001 Eur. J. Pharmacol. pmid:11438300
Zhang X et al. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2. 2001 J. Immunol. pmid:11390455
Inoue T et al. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. 2001 Thromb. Haemost. pmid:11204569
Hirai H et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. 2001 J. Exp. Med. pmid:11208866
Guan Y et al. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. 2001 Am. J. Physiol. Renal Physiol. pmid:11704554
Bochenek G et al. [Prostaglandin D2: biosynthesis, biological properties and participation in bronchial asthma]. 2001 Pol. Arch. Med. Wewn. pmid:11928572
Azuma Y et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-10 and IL-12 production by macrophages. 2001 Biochem. Biophys. Res. Commun. pmid:11327705
Equils O et al. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. 2001 J. Immunol. pmid:11160291
Wilmer WA et al. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. 2001 Biochem. Biophys. Res. Commun. pmid:11178960
Kang SS et al. Cyclooxygenase-2 inhibitory cerebrosides from phytolaccae radix. 2001 Chem. Pharm. Bull. pmid:11253924
Okayama Y et al. A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI. 2001 J. Immunol. pmid:11254731
Fahmi H et al. Peroxisome proliferator--activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. 2001 Arthritis Rheum. pmid:11263774
Hsieh FH et al. T helper cell type 2 cytokines coordinately regulate immunoglobulin E-dependent cysteinyl leukotriene production by human cord blood-derived mast cells: profound induction of leukotriene C(4) synthase expression by interleukin 4. 2001 J. Exp. Med. pmid:11136826
Tunaz H et al. Prostaglandin biosynthesis by fat body from true armyworms, Pseudaletia unipuncta. 2001 Insect Biochem. Mol. Biol. pmid:11222953
Person EC et al. Albumin regulates induction of peroxisome proliferator-activated receptor-gamma (PPARgamma) by 15-deoxy-delta(12-14)-prostaglandin J(2) in vitro and may be an important regulator of PPARgamma function in vivo. 2001 Endocrinology pmid:11159824
Reilly CM et al. Prostaglandin J(2) inhibition of mesangial cell iNOS expression. 2001 Clin. Immunol. pmid:11237557
Kitamura Y et al. Effects of 15-deoxy-delta(12,14) prostaglandin J(2) and interleukin-4 in Toll-like receptor-4-mutant glial cells. 2001 Eur. J. Pharmacol. pmid:11164379
Kadekaro M et al. Central interactions between angiotensin II and PGD(2) in the regulation of vasopressin and oxytocin secretion in dehydrated rats. 2001 Brain Res. pmid:11166690
Szczeklik A et al. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. 2001 Clin. Exp. Allergy pmid:11251623
Nielsen PN et al. Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study. 2001 Clin. Exp. Allergy pmid:11591187
Satoh K et al. Lipid peroxidation end products-responded induction of a preneoplastic marker enzyme glutathione S-transferase P-form (GST-P) in rat liver on admistration via the portal vein. 2001 Mutat. Res. pmid:11600134
Kitatani K et al. Ceramide accelerates dephosphorylation of extracellular signal-regulated kinase 1/2 to decrease prostaglandin D(2) production in RBL-2H3 cells. 2001 Arch. Biochem. Biophys. pmid:11697858
Levonen AL et al. Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. 2001 Arterioscler. Thromb. Vasc. Biol. pmid:11701476
Ianaro A et al. Role of cyclopentenone prostaglandins in rat carrageenin pleurisy. 2001 FEBS Lett. pmid:11707269
Azuma Y et al. 15-Deoxy-delta(12,14)-prostaglandin J2 is a negative regulator of macrophage functions. 2001 Int. Immunopharmacol. pmid:11710539
Robbins IM et al. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. 2001 Chest pmid:11713147
Jozkowicz A et al. Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner. 2001 Prostaglandins Other Lipid Mediat. pmid:11577781
Garcia Palacios V et al. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728175
Levine L Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728177
Tanimoto A et al. Histamine increases the expression of LOX-1 via H2 receptor in human monocytic THP-1 cells. 2001 FEBS Lett. pmid:11728449
Mizoguchi A et al. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11562489
Inoue K et al. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists. 2001 Biochem. Biophys. Res. Commun. pmid:11563856
Clay CE et al. Early de novo gene expression is required for 15-deoxy-Delta 12,14-prostaglandin J2-induced apoptosis in breast cancer cells. 2001 J. Biol. Chem. pmid:11668172
Monneret G et al. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. 2001 Blood pmid:11535533
Akrishnan VR and Menon VP Potential role of antioxidants during ethanol-induced changes in the fatty acid composition and arachidonic acid metabolites in male Wistar rats. 2001 Cell Biol. Toxicol. pmid:11504446
Chiba Y et al. PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells. 2001 Biochem. Biophys. Res. Commun. pmid:11511093
Kozawa O et al. Mechanism of prostaglandin D(2)-stimulated heat shock protein 27 induction in osteoblasts. 2001 Cell. Signal. pmid:11483406
Nakashiro KI et al. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells. 2001 Am. J. Pathol. pmid:11485917
Takashima T et al. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. 2001 Int. J. Oncol. pmid:11494023
Rovin BH et al. Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells. 2001 J. Am. Soc. Nephrol. pmid:11461938
Cernuda-Morollón E et al. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit. 2001 J. Biol. Chem. pmid:11466314
Boyault S et al. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. 2001 FEBS Lett. pmid:11457450
Nishimura H et al. Acute effects of prostaglandin D2 to induce airflow obstruction and airway microvascular leakage in guinea pigs: role of thromboxane A2 receptors. 2001 Prostaglandins Other Lipid Mediat. pmid:11519790
Clay CE et al. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. 2001 J. Investig. Med. pmid:11523697
Hunter JG et al. Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma -dependent and -independent pathways. 2001 J. Biol. Chem. pmid:11477074